KRISTINA KAMBURIS: Open Payments
NPI 1720518400 · AUBURN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 62 payments from 11 companies in 2025. Trend: 2023 $125 · 2024 $2,039 · 2025 $915
Food & beverage: $915
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $353 |
| Janssen Biotech, Inc. | 9 | $241 |
| Novartis Pharmaceuticals Corporation | 3 | $65 |
| Amgen Inc. | 3 | $63 |
| Organon LLC | 3 | $46 |
| PFIZER INC. | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 2 | $31 |
| Lilly USA, LLC | 1 | $23 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
Products named: RINVOQ, TREMFYA, SKYRIZI, OTEZLA, CIBINQO, Sotyktu, VTAMA, EBGLYSS.
Industry payments across AL — which companies pay providers there.
